Sanjay Shukla

ATYR

Sanjay Shukla serves as director, officer: President and CEO at aTyr Pharma, Inc. (ATYR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

9 trades

$260.6K

Total Sells

2 trades

$7.3K

Net Position

Net Buyer

$253.3K

Companies Traded

ATYR

Active Period

May 2021 – Feb 2026

11 total trades

Most Recent

Sell ATYR

Feb 4, 2026 · $3.7K

Sanjay Shukla's Insider Trading at aTyr Pharma, Inc. (ATYR)

Buys

9 · $260.6K

Sells

2 · $7.3K

Total Shares Bought

107,500

Total Shares Sold

7,490

ATYR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 4, 2026	Sell	3,745	$0.98	$3.7K	153,553
Feb 3, 2026	Sell	3,745	$0.98	$3.7K	0
May 31, 2024	Buy	20,000	$1.81	$36.1K	0
Dec 11, 2023	Buy	15,000	$1.18	$17.6K	0
Nov 10, 2023	Buy	15,000	$1.11	$16.7K	0
Jul 28, 2023	Buy	15,000	$2.01	$30.2K	0
Nov 21, 2022	Buy	10,000	$2.14	$21.4K	0
Jul 1, 2022	Buy	15,000	$2.88	$43.2K	0
Jan 7, 2022	Buy	5,000	$6.76	$33.8K	0
Nov 15, 2021	Buy	2,500	$8.58	$21.4K	0
May 18, 2021	Buy	10,000	$4.01	$40.1K	0

Related Insiders

Jill Marie Broadfoot

officer: Chief Financial Officer

ATYRSell · Feb 4, 2026

DENYES NANCY

officer: General Counsel

ATYRSell · Feb 4, 2026

SCHIMMEL PAUL

Director

ATYRBuy · Oct 8, 2025

Explore More Insider Trading Data

ATYR Insider Trading Activity

View all insider trades at aTyr Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity